| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/15/2003 | CN1098930C GRB3-3 gene, variants and uses thereof |
| 01/14/2003 | US6506962 Disease resistance |
| 01/14/2003 | US6506917 Ligands which are more selective for retinoid X receptor than is retinoic acid |
| 01/14/2003 | US6506893 Polynucleotides and their use for detecting resistance to streptogramin A or to streptogramin B and related compounds |
| 01/14/2003 | US6506892 Interleukin X (IL-X) controls cellular proliferation; anticarcinogenic agents |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506889 Ras suppressor SUR-8 and related compositions and methods |
| 01/14/2003 | US6506888 Viricides, antitumor and anticarcinogenic agents |
| 01/14/2003 | US6506884 Variant of vascular endothelial growth factor |
| 01/14/2003 | US6506883 Humanized and chimeric monoclonal antibodies that recognize epidermal growth factor receptor (EGF-R); diagnostic and therapeutic use |
| 01/14/2003 | US6506881 Specific for human milk fat globule; complementarity determining region derived from variable domains of mouse monoclonal antibody |
| 01/14/2003 | US6506880 For inhibiting atherosclerosis |
| 01/14/2003 | US6506879 Endotoxin-free; genetically expressed in bacteria; atherosclerosis and cardiovascular disorder treatment |
| 01/14/2003 | US6506878 HMTF81 human 7-transmembrane receptor |
| 01/14/2003 | US6506877 Ob receptor |
| 01/14/2003 | US6506875 Diagnostic epitopes |
| 01/14/2003 | US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506731 Elastin peptide analogs and methods of using same |
| 01/14/2003 | US6506729 Methods and compositions for the treatment and prevention of Parkinson's disease |
| 01/14/2003 | US6506728 Methods using a novel neurotrophic factor, NT-4 |
| 01/14/2003 | US6506725 Ultra pure hemoglobin solutions and blood-substitutes |
| 01/14/2003 | US6506607 Methods and compositions for the identification and assessment of prostate cancer therapies and the diagnosis of prostate cancer |
| 01/14/2003 | US6506604 Retroviral packaging system |
| 01/14/2003 | US6506603 DNA reassembly after random fragmentation; mutagenesis cycles; denaturing, incubation, genetic engineering, screening |
| 01/14/2003 | US6506602 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 01/14/2003 | US6506595 DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs |
| 01/14/2003 | US6506590 Plasmids, their construction and their use in the manufacture of interleukin-4 and interleukin-4 muteins |
| 01/14/2003 | US6506582 Extended by aspartic acid at 5' end and shortened at 3' end by one to eight amino acids; nonimmunogenic; binds CD4 lymphocytes |
| 01/14/2003 | US6506581 Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof |
| 01/14/2003 | US6506580 Splice variants for human 5-HT4 serotonin receptor and their applications, in particular for screening |
| 01/14/2003 | US6506579 Increasing production of proteins in gram-positive microorganisms using SecG |
| 01/14/2003 | US6506577 Synthesis and crosslinking of catechol containing copolypeptides |
| 01/14/2003 | US6506569 Drug screening; genetic engineering |
| 01/14/2003 | US6506565 Transgenic plant; genetic engineering |
| 01/14/2003 | US6506557 Methods and compositions for identifying a protease |
| 01/14/2003 | US6506554 Drug screening for viricides |
| 01/14/2003 | US6506553 Method for diagnosis of Epstein-Barr virus associated disease |
| 01/14/2003 | US6506550 Inducing apoptosis in cancer cells; drug screening for thiamine-depleting agents |
| 01/14/2003 | US6506411 Anti-angiogenic compositions and methods of use |
| 01/14/2003 | US6506389 Adherence factors of non pathogenic microorganisms and applications thereof for screening microorganisms for specific probiotic properties; novel pharmaceutical compositions and food additives comprising such microorganisms and adherence factors |
| 01/14/2003 | US6506382 Method for inhibiting reperfusion injury using antibodies to P-selectin glycoprotein ligand |
| 01/14/2003 | US6506379 Intramuscular delivery of recombinant AAV |
| 01/14/2003 | US6506365 Fibrin/fibrinogen binding conjugate |
| 01/14/2003 | US6506362 Peptides and peptide mimetics attached to labels and/or hydrophilic polymmers; treating hematological disorders, particularly thrombocytopenia resulting from chemotherapy, radiation therapy, or bone marrow transfusions |
| 01/14/2003 | CA2246758C Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 01/14/2003 | CA2229739C Recombinant conglutinin and producing method thereof |
| 01/14/2003 | CA2194444C Immunomodulators |
| 01/14/2003 | CA2115249C Phosphopeptides for the treatment of dental calculus |
| 01/14/2003 | CA2114313C Bpc peptides, their preparation and use |
| 01/14/2003 | CA2102595C Truncated forms of the hepatocyte growth factor (hgf) receptor |
| 01/14/2003 | CA2086922C Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 01/14/2003 | CA2027355C Yeast promoter |
| 01/10/2003 | CA2390522A1 Enzyme/tag binding and detection system |
| 01/09/2003 | WO2003003019A2 Process of purification of amyloid fibrils |
| 01/09/2003 | WO2003003013A1 Non-nuclear effects of thyroid hormone |
| 01/09/2003 | WO2003003010A1 Pael receptor, cells and animal expressing pael receptor and method of screening remedy for parkinson’s disease |
| 01/09/2003 | WO2003002754A2 Bri constructs and methods of using |
| 01/09/2003 | WO2003002751A2 Alteration of oil traits in plants |
| 01/09/2003 | WO2003002749A2 Methods for the simultaneous detection of hcv antigens and hcv antibodies |
| 01/09/2003 | WO2003002746A2 Perv screening method and use thereof |
| 01/09/2003 | WO2003002745A2 The cage gene of actinobacillus actinomycetemcomitans, the protein it encodes and uses thereof |
| 01/09/2003 | WO2003002744A1 Human cervical cancer 2 proto-oncogene and protein encoded therein |
| 01/09/2003 | WO2003002743A1 Human cervical cancer 7 proto-oncogene and protein encoded therein |
| 01/09/2003 | WO2003002742A1 Nucleic acid participating in the formation of presenilin-2-gene exon 5-defective splicing variant |
| 01/09/2003 | WO2003002741A2 Nucleic acids encoding nuclear receptors |
| 01/09/2003 | WO2003002737A1 Novel human topoisomerase 2α inhibitory protein and utilization thereof |
| 01/09/2003 | WO2003002736A2 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 01/09/2003 | WO2003002734A1 Anticomplement polypeptide from salivary glands of the tick ixodes ricinus |
| 01/09/2003 | WO2003002726A2 Cellular reporter gene assay with a ligand amplifying feedback loop |
| 01/09/2003 | WO2003002724A2 Proteins, druggable regions of proteins and target analysis for chemistry of therapeutics |
| 01/09/2003 | WO2003002722A2 T cell regulatory genes and methods of use thereof |
| 01/09/2003 | WO2003002718A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 01/09/2003 | WO2003002717A2 Biological activity of ak155 |
| 01/09/2003 | WO2003002611A2 Fusion proteins, method for the production and use thereof |
| 01/09/2003 | WO2003002610A1 Extracellular messengers |
| 01/09/2003 | WO2003002606A2 Nucleic acids encoding ion channels |
| 01/09/2003 | WO2003002605A2 Human secretin-like g protein-coupled receptor |
| 01/09/2003 | WO2003002604A2 G protein coupled receptors and dna sequences thereof |
| 01/09/2003 | WO2003002603A1 Novel neuropeptide y-like peptide |
| 01/09/2003 | WO2003002602A2 Nogo and nogo receptor derived peptides for t-cell mediated neuroprotection |
| 01/09/2003 | WO2003002601A2 AFXz TRANSCRIPTION FACTOR SPLICE FORM |
| 01/09/2003 | WO2003002600A1 Use of soluble cytokeratine-1-fragments in diagnostics and therapy |
| 01/09/2003 | WO2003002599A2 Immune-related proteins and the regulation of the same |
| 01/09/2003 | WO2003002598A2 Peptides for use as translocation factors |
| 01/09/2003 | WO2003002597A2 Therapeutic modulation of chemokines using a helminth parasite chemokine-binding protein |
| 01/09/2003 | WO2003002591A2 Tlp antigen extract, its preparation and diagnostic applications thereof |
| 01/09/2003 | WO2003002155A1 Vector encoding human globlin gene and use thereof in treatment of hemoglobinopathies |
| 01/09/2003 | WO2003002152A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 01/09/2003 | WO2003002146A1 Medicinal compositions |
| 01/09/2003 | WO2003002143A1 A novel engineered superantigen for human therapy |
| 01/09/2003 | WO2003002142A1 Cancer vaccine containing cancer antigen based on tumor suppressor gene wt1 product and cationic liposomes |
| 01/09/2003 | WO2003002138A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| 01/09/2003 | WO2003002137A2 Trp1, mct, or ftz-f1 homologous proteins involved in the regulation of energy homeostasis |
| 01/09/2003 | WO2003002136A2 Stable formulation of modified glp-1 |
| 01/09/2003 | WO2003002105A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | WO2003002087A1 Use of a lys-pro-val (kpv) tripeptide in cosmetics |
| 01/09/2003 | WO2003002067A2 Inhibition of tumor growth and metastasis by n5 gene |
| 01/09/2003 | WO2003002065A2 Hcv e1e2 vaccine compositions |
| 01/09/2003 | WO2003002061A2 Compositions and methods for treating atherosclerosis |